Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Archives of Gerontology and Geriatrics|May 15, 2020
How can we evaluate an interrelation of symptoms?Takuma Usuzaki, Shuji Chiba, Minoru Shimoyama
Hinyokika Kiyo. Acta Urologica Japonica|January 21, 2017
[Two Cases of Urinary Retention with Prostatic Abscess Drained by Transurethral Resection]Yoshinori Matsuda, Takamitsu Inoue, Shuji Chiba, et al.
International Health|November 1, 2020
A disparity in the number of studies related to COVID-19 and SARS-CoV-2 between low- and middle-income countries and high-income countriesTakuma Usuzaki, Shuji Chiba, Minoru Shimoyama, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 12, 2011
[Granulocyte colony stimulating factor-producing spindle cell renal cell carcinoma successfully treated by chemotherapy consisting of gemcitabine and doxorubicin]Souhei Kanda, Takamitsu Inoue, Hiroshi Tsuruta, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 8, 2020
[The Initial Results of Robot-Assisted Pyeloplasty in Comparison with Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction]Mizuki Kobayashi, Takamitsu Inoue, Taketoshi Nara, et al.
Acta Physiologica (Oxford, England)|April 8, 2025
Cav3.1 T-Type Calcium Channel Acts as a Gateway for GABAergic Excitation in the Medial Prefrontal Cortex That Leads to Chronic Psychological Stress Responses in MiceYasushi Yabuki, Karin Hori, Zizhen Zhang, et al.
International Journal of Clinical Oncology|June 24, 2022
Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxelShintaro Narita, Takahiro Kimura, Shingo Hatakeyama, et al.
World Journal of Urology|February 26, 2022
Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapyShintaro Narita, Takahiro Kimura, Shingo Hatakeyama, et al.
Medical Oncology (Northwood, London, England)|March 13, 2021
Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in JapanYumina Muto, Shintaro Narita, Shingo Hatakeyama, et al.
The Prostate|September 30, 2024
Prognostic model for second progression-free survival and overall survival in patients with high-risk metastatic hormone-sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapyShintaro Narita, Takafumi Yanagisawa, Shingo Hatakeyama, et al.
Pageof 1